CPHARM - CRC Study
ConditionColorectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-75
SponsorMonash University Malaysia
About this trial
Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low.
Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 50 to 75 years
Visiting participating community pharmacies during the study period
Able to provide informed consent
Willing to complete the study questionnaire
Disqualifiers
Previous diagnosis of colorectal cancer
History of colonoscopy within the recommended screening interval (within past 1 year)
Currently experiencing symptoms suggestive of colorectal cancer
Having a first-degree relative diagnosed with colorectal cancer
Trial design
Design model
Parallel
Treatments tested in this trial
Health awareness campaign
BehavioralCampaign Components The one-day Ribbon of Hope campaign will be implemented at each intervention pharmacy to promote colorectal cancer awareness and screening uptake. The campaign consists of educational materials and one-on-one education about colorectal cancer.
Treatment groups
316 Participants
are divided into 2 treatment groupsGroup A: Pharmacy customers with campaignExperimental treatment 1 intervention
Group B: Pharmacy customers without campaignNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Beliefs and perceptions toward colorectal cancer and iFOBT screening
Beliefs and perceptions toward colorectal cancer and iFOBT screening, measured using the Champion Health Belief Model Scale - Colorectal Cancer - Malay (CHBMS-CRC-M) subscales of perceived susceptibility, perceived benefits, and perceived barriers, between customers from pharmacies with and without the one-day awareness campaign. Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores will be calculated by summing (or averaging) the items within each domain, with higher scores indicating greater perceived susceptibility, benefits or barriers.
Time frame
From enrollment to the 8th week follow-up.Secondary outcomes
1
Proportion of participants who were willing to accept and perform iFOBT, report iFOBT results, and follow-up if needed.
Time frame
From enrollment to the 8th week of follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: